Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial
-
Published:2023-05-05
Issue:1
Volume:23
Page:
-
ISSN:1471-2261
-
Container-title:BMC Cardiovascular Disorders
-
language:en
-
Short-container-title:BMC Cardiovasc Disord
Author:
Heutinck Joyce M.,De Koning Iris A.,Vromen Tom,Van Geuns Robert-Jan M.,Thijssen Dick H.J.,Kemps Hareld M.C.,Adang Eddy M.,Geleijnse Johanna M.,van Gorp Pieter,van ‘t Hof Arnoud W. J.,Janssen Veronica R.,Jorstad Harald T.,Kraaijenhagen Roderik A.,Lammers Jeroen,de Man Frits H. A. F.,Nollen Gijs J.,van Ofwegen-Hanekamp Clara E. E.,Onkelinx Steven,Oostveen Laurence M. L. C.,Roes Kit C. B.,Sunamara Madoka,Tonino Pim A. L.,
Abstract
Abstract
Background
Currently, in the majority of patients with stable angina pectoris (SAP) treatment consists of optimal medical treatment, potentially followed by coronary angiography and subsequent coronary revascularisation if necessary”. Recent work questioned the effectiveness of these invasive procedures in reducing re-events and improving prognosis. The potential of exercise-based cardiac rehabilitation on clinical outcomes in patients with coronary artery disease is well-known. However, in the modern era, no studies compared the effects of cardiac rehabilitation versus coronary revascularisation in patients with SAP.
Methods
In this multicentre randomised controlled trial, 216 patients with stable angina pectoris and residual anginal complaints under optimal medical treatment will be randomised to: 1) usual care (i.e., coronary revascularisation), or 2) a 12-month cardiac rehabilitation (CR) programme. CR consists of a multidisciplinary intervention, including education, exercise training, lifestyle coaching and a dietary intervention with a stepped decline in supervision. The primary outcome will be anginal complaints (Seattle Angina Questionnaire-7) following the 12-month intervention. Secondary outcomes include cost-effectiveness, ischemic threshold during exercise, cardiovascular events, exercise capacity, quality of life and psychosocial wellbeing.
Discussion
In this study, we will examine the hypothesis that multidisciplinary CR is at least equally effective in reducing anginal complaints as the contemporary invasive approach at 12-months follow-up for patients with SAP. If proven successful, this study will have significant impact on the treatment of patients with SAP as multidisciplinary CR is a less invasive and potentially less costly and better sustainable treatment than coronary revascularisations.
Trial registration
Netherlands Trial Register, NL9537. Registered 14 June 2021.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference48 articles.
1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):2564–603. 2. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77. 3. de Vries H, Kemps HM, van Engen-Verheul MM, Kraaijenhagen RA, Peek N. Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. Eur Heart J. 2015;36(24):1519–28. 4. Smits PC, Marteijn M, De Boer AR, Bots ML, Van Dis I, Vaartjes I, Hart- envaatziekten in Nederland, et al. cijfers over risicofactoren, hartinterventies, ziekte en sterfte. Hart- en vaatziekten in Nederland 2018, cijfers over risicofactoren, hartinterventies, ziekte en sterfte. Den Haag: Hartstichting. 2018;2018:81–90. 5. Registry NCD. Nationale rapportage 2014 & ACS snapshotweken. Staat voor Registratie, Transparantie en Kwaliteit. 2014.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|